Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LOC102723600 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CROCCP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUDT16P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPS15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CACNB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF207 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FRG1CP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MPPED2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OBSL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SBF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DHX30 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100652930 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNRF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGAP39 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PNISR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LTBP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAPS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on